World Pharma Newsfeed
Bayer increases sales and earnings in the second quarter
Sales of the Bayer Group rose by 14.6 percent in the second quarter, to EUR 9,179 million (Q2 2009: EUR 8,009 million). ...
FDA Grants Priority Review to Cladribine Tablets
Merck KGaA announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (...
Lilly Reports Strong Second-Quarter 2010 Results
Eli Lilly and Company (NYSE: LLY) announced financial results for the second quarter of 2010. In the second quarter of 2...
Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has reservations on approval by the U.S. Food and Drug Administration (FDA)...
Tracking down neuromuscular diseases
Neuromuscular diseases (NMDs) are chronic and so far incurable conditions that gradually affect patients' muscles, leadi...
Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®
Sandoz announced the introduction of enoxaparin sodium injection, the first generic version of Lovenox®[1], in the US. P...
Roche posts good half year results
The Roche Group posted strong operating results in the first half of 2010. Group sales grew by 5% in local currencies (3...
Pfizer to Offer Free Public Access to Mental Health Assessment Tools
As part of its commitment to improving the quality of patient care, Pfizer (NYSE: PFE) will make available assessment sc...
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth
Bristol-Myers Squibb Company (NYSE: BMY) reported results for the second quarter of 2010 which featured data on key mark...
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
GlaxoSmithKline [NYSE: GSK] confirmed that it will suspend enrollment of new patients in the Thiazolidinedione Intervent...
